Hydrocodone Bitartrate And Acetaminophen
Product Images NDC 16590-115

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Hydrocodone Bitartrate And Acetaminophen (NDC 16590-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Hb Apap 10 325 mg Label 118)

FDA Label Image

Label Image (Hb Apap 10 500 mg Label 119)

Packaged and sold in Gainesville, this medication contains Hydrocodone Bit. and Acetamin. The NDC numbers are 16590-119-60 and 05910540-05. It is manufactured by Watson Pharmaceuticals in Corona, CA and may cause drowsiness if taken with alcohol. The lot number for one of the samples is HB26812. There is also a "Discard Alert" related to a sample with batch number BW 71312012.*

FDA Label Image

Label Image (Hb Apap 10 650 mg Label 120)

This is a label of a medication called "Hydrocodone Bit./Acefamin" with a strength of 10/650mg. It has been distributed by Walson Pharma, Inc. The medication comes in a tablet form and the bottle contains 30 tablets. The lot number on this label is "HB26812", the discard after date is "12113" and the sample appears to be for some future analysis. The label cautions that Federal law prevents sharing the medication with others and that the medication may cause drowsiness. It warns that the use of alcohol may increase the risk of drowsiness when taking this medication.*

FDA Label Image

Label Image (Hb Apap 2 5 500 mg Label 112)

This is a description of a packaged medicine that contains Hydrocodone Bit and Acetaminophen. The manufacturer and distributor of the medicine is listed as DX STAT K US/Sanesate and Watson Pharma, respectively. The package contains tablets that may cause drowsiness and users are cautioned against operating dangerous machinery. The lot number is HB25812 and the expiration date is December 7, 2013. Alcohol consumption may intensify the effects of the medicine.*

FDA Label Image

Label Image (Hb Apap 7 5 325 mg Label 114)

This text appears to be a description of a medication package containing tablets with the ingredients Hydrocodone Bit and Acetaminophen. The package was distributed by Walson Pharma, Inc. with a lot number of 2073055, and the tablets have an NDC identifier of 1659011430. The text includes a warning that the medication may cause drowsiness and may be intensified by alcohol, so care should be taken when operating machinery.*

FDA Label Image

Label Image (Hb Apap 7 5 500 mg Label 115)

Not-Available*

FDA Label Image

Label Image (Hb Apap 7 5 650 mg Label 116)

Each tablet of Hydrocodone Bit./Acetamin contains 7.5/650mg. This medication is distributed by Watson Pharma, Inc. and the lot number is 237956. It may cause drowsiness and alcohol can intensify its effects. Use with care.*

FDA Label Image

Label Image (Hb Apap 7 5 750 mg Label 117)

This appears to be the text found on a prescription medication. The medication is a tablet containing two active ingredients - Hydrocodone and Acetaminophen. The medication carries a caution about drowsiness and the potential for the medication's effects to be intensified when combined with alcohol. Additionally, users are advised to use care when operating dangerous machinery. There is also information about the medication's lot number and discard date.*

FDA Label Image

Structural Formula For Hydrocodone Bitartrate (Hydrocodone Bitartrate And Apap Tablets Multi Stre 1)

FDA Label Image

Structural Formula For Acetaminophen (Hydrocodone Bitartrate And Apap Tablets Multi Stre 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.